Toggle Main Menu Toggle Search

Open Access padlockePrints

Quinolinone and pyridopyrimidinone inhibitors of DNA-dependent protein kinase

Lookup NU author(s): Dr Olivier Barbeau, Dr Celine CanoORCiD, Professor Roger Griffin, Dr Ian HardcastleORCiD, Professor William Clegg, Dr Ross Harrington, Emeritus Professor Bernard Golding

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

8- Substituted 2- morpholin- 4- yl- quinolin- 4- ones and 9- substituted 2- morpholin- 4- ylpyrido[ 1,2- a] pyrimidin- 4- ones with selected aryl and heteroaryl groups as the substituent have been synthesised as potential inhibitors of DNA- dependent protein kinase. A multiple- parallel approach, employing Suzuki cross- coupling methodology, was utilised in the preparation of 8- substituted 2- morpholin- 4- yl- quinolin- 4- ones. For this purpose 8- bromo- 2- morpholin- 4- yl- quinolin- 4- one was required as an intermediate. This compound was obtained by adapting a literature route in which thermal cyclocondensation of ( 2- bromoanilino)- morpholin- 4- yl- 5- methylene- 2,2- dimethyl[ 1,3] dioxane4,6- dione afforded 8- bromo- 2- morpholin- 4- yl- quinolin- 4- one. A multiple- parallel approach, employing Suzuki cross- coupling methodology, was also utilised to prepare 9- substituted 2- morpholin- 4- ylpyrido[ 1,2- a] pyrimidin- 4- ones using 9- hydroxy- 2- morpholin- 4- yl- pyrido[ 1,2- a] pyrimidin- 4- one O- trifluoromethanesulfonate as an intermediate. 8- Substituted 2- morpholin- 4- yl- quinolin- 4- ones and 9- substituted 2- morpholin- 4- yl- pyrido[ 1,2- a] pyrimidin- 4- ones were both inhibitors of DNA- dependent protein kinase. When the substituent was dibenzothiophen- 4- yl, dibenzofuran- 4- yl or biphen- 3- yl, IC50 values in the low nanomolar range were observed. Interestingly, the pyridopyrimidinones and quinolinones were essentially equipotent with the corresponding 8- substituted 2- morpholin- 4yl- chromen- 4- ones previously reported ( I. R. Hardcastle, X. Cockcroft, N. J. Curtin, M. Desage El- Murr, J. J. J. Leahy, M. Stockley, B. T. Golding, L. Rigoreau, C. Richardson, G. C. M. Smith and R. J. Grif. n, J. Med. Chem., 2005, 48, 7829 - 7846).


Publication metadata

Author(s): Barbeau OR, Cano-Soumillac C, Griffin RJ, Hardcastle IR, Smith GCM, Richardson C, Clegg W, Harrington RW, Golding BT

Publication type: Article

Publication status: Published

Journal: Organic & Biomolecular Chemistry

Year: 2007

Volume: 5

Issue: 16

Pages: 2670-2677

ISSN (print): 1477-0520

ISSN (electronic): 1477-0539

URL: http://dx.doi.org/10.1039/b705095j

DOI: 10.1039/b705095j

PubMed id: 18019542


Altmetrics

Altmetrics provided by Altmetric


Share